Alzheimer Disease Clinical Trial
— MEMTRAV-COGOfficial title:
Efficacy of Working Memory Maintenance Mechanisms in Alzheimer's Disease and Vascular Dementia
The aim of the present study is to investigate potential cognitive mechanisms contributing to working memory impairment in Alzheimer's disease and vascular dementia. The investigators consider a new hypothesis suggesting that difficulties in mobilizing maintenance strategies of information could explain this working memory deficit. More specifically, the investigators assume that patient groups will have difficulties in employing both refreshing and elaborative strategies during a working memory task (i.e., complex span task), as compared to a control group.
Status | Not yet recruiting |
Enrollment | 120 |
Est. completion date | October 2025 |
Est. primary completion date | September 2025 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 65 Years and older |
Eligibility | Inclusion Criteria: - For patient and control groups: Adults = 65 years of age - For patient and control groups: Native French speaker - For patient and control groups: Vision for easy reading - For patient and control groups: Hearing for easy instruction understanding - For patient and control groups: Back span = 3 during the "Digit Span Backward" subtest (WAIS-IV) - For patient and control groups: Formulation of the non-opposition to participate in this study - For patient group only: Consultation in Grenoble University Hospital (Centre de Gérontologie Sud - Gerontology center) for clinical neuropsychological assessment due to suspected cognitive impairment - For patient group only: Diagnosis of Alzheimer's disease, vascular dementia, or mixed dementia (i.e., Alzheimer's disease and vascular dementia) - For patient group only: Have undergone a neuropsychological assessment at the day clinic, less than 6 months old. - For patient group only: Have obtained a medical opinion stating that there is no contraindication to participate in this study and no concurrent pathology that could impair the patient's cognitive abilities. - For patient group only: Absence of praxis and language disorders thath might prevent the carrying out of the experimental task. - For patient group only: MMSE score between 18 and 25 included - For control group only: External visitor/carer of a patient/resident of Grenoble University Hospital or volunteers at Grenoble University Hospital. - For control group only: MMSE score = 26 Exclusion Criteria: - For patient and control groups: People under guardianship or deprived of their freedom - For patient and control groups: Diagnosis of severe psychiatric disorders - For patient and control groups: Suspicion of pathologies related to alcohol dependence - For patient and control groups: No French social security coverage - For patient and control groups: Refusal to voluntarily participate in this study - For patient and control groups: People covered by articles L1121-5 to L1121-8 of the French Public Health Code - For patient group only: Suspicion of another neurodegenerative disease, such as fronto-temporal dementia, Parkinson's disease, Lewy body disease. - For patient group only: Clinical neuropsychological assessment did not reveal any cognitive impairment. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Grenoble | Centre National de la Recherche Scientifique, France, Laboratoire de Psychologie et NeuroCognition, Université Savoie Mont Blanc, University Grenoble Alps |
Baddeley AD, Baddeley HA, Bucks RS, Wilcock GK. Attentional control in Alzheimer's disease. Brain. 2001 Aug;124(Pt 8):1492-508. doi: 10.1093/brain/124.8.1492. — View Citation
Bartsch LM, Singmann H, Oberauer K. The effects of refreshing and elaboration on working memory performance, and their contributions to long-term memory formation. Mem Cognit. 2018 Jul;46(5):796-808. doi: 10.3758/s13421-018-0805-9. — View Citation
Bayard, S., Erkes, J., & Moroni, C. (2009). Test du Stroop Victoria-Adaptation Francophone. CPCN-LR, Gignac.
Belleville S, Chertkow H, Gauthier S. Working memory and control of attention in persons with Alzheimer's disease and mild cognitive impairment. Neuropsychology. 2007 Jul;21(4):458-69. doi: 10.1037/0894-4105.21.4.458. — View Citation
Belleville S, Peretz I, Malenfant D. Examination of the working memory components in normal aging and in dementia of the Alzheimer type. Neuropsychologia. 1996 Mar;34(3):195-207. doi: 10.1016/0028-3932(95)00097-6. — View Citation
Camos V, Johnson M, Loaiza V, Portrat S, Souza A, Vergauwe E. What is attentional refreshing in working memory? Ann N Y Acad Sci. 2018 Jul;1424(1):19-32. doi: 10.1111/nyas.13616. Epub 2018 Mar 15. — View Citation
Conway AR, Kane MJ, Bunting MF, Hambrick DZ, Wilhelm O, Engle RW. Working memory span tasks: A methodological review and user's guide. Psychon Bull Rev. 2005 Oct;12(5):769-86. doi: 10.3758/bf03196772. — View Citation
Craik, F. I. M., & Tulving, E. Depth of processing and the retention of words in episodic memory. Journal of Experimental Psychology (1975). General, 104, 268-294.
Foley JA, Cocchini G, Logie RH, Della Sala S. No dual-task practice effect in Alzheimer's disease. Memory. 2015;23(4):518-28. doi: 10.1080/09658211.2014.908922. Epub 2014 Apr 30. — View Citation
Folstein MF, Folstein SE, McHugh PR. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189-98. doi: 10.1016/0022-3956(75)90026-6. No abstract available. — View Citation
Gagnon LG, Belleville S. Working memory in mild cognitive impairment and Alzheimer's disease: contribution of forgetting and predictive value of complex span tasks. Neuropsychology. 2011 Mar;25(2):226-36. doi: 10.1037/a0020919. — View Citation
Grober E., & Buschke H. . Genuine memory deficits in dementia. Developmental Neuropsychology,(1987) 5, 13-36.
Inasaridze K, Foley JA, Logie RH, Sala SD. Dual task impairments in vascular dementia. Behav Neurol. 2010;22(1-2):45-52. doi: 10.3233/BEN-2009-0252. — View Citation
Jahn H. Memory loss in Alzheimer's disease. Dialogues Clin Neurosci. 2013 Dec;15(4):445-54. doi: 10.31887/DCNS.2013.15.4/hjahn. — View Citation
Jellinger KA, Attems J. Prevalence and pathology of vascular dementia in the oldest-old. J Alzheimers Dis. 2010;21(4):1283-93. doi: 10.3233/jad-2010-100603. — View Citation
KATZ S, FORD AB, MOSKOWITZ RW, JACKSON BA, JAFFE MW. STUDIES OF ILLNESS IN THE AGED. THE INDEX OF ADL: A STANDARDIZED MEASURE OF BIOLOGICAL AND PSYCHOSOCIAL FUNCTION. JAMA. 1963 Sep 21;185:914-9. doi: 10.1001/jama.1963.03060120024016. No abstract available. — View Citation
Korczyn AD, Vakhapova V, Grinberg LT. Vascular dementia. J Neurol Sci. 2012 Nov 15;322(1-2):2-10. doi: 10.1016/j.jns.2012.03.027. Epub 2012 May 8. — View Citation
Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969 Autumn;9(3):179-86. No abstract available. — View Citation
Logie, R., Camos, V., & Cowan, N. Working memory: State of the science. Oxford University Press. (2020).
McGuinness B, Barrett SL, Craig D, Lawson J, Passmore AP. Executive functioning in Alzheimer's disease and vascular dementia. Int J Geriatr Psychiatry. 2010 Jun;25(6):562-8. doi: 10.1002/gps.2375. — View Citation
O'Brien JT, Thomas A. Vascular dementia. Lancet. 2015 Oct 24;386(10004):1698-706. doi: 10.1016/S0140-6736(15)00463-8. — View Citation
Raoux N, Le Goff M, Auriacombe S, Dartigues JF, Amieva H. [Semantic and letter fluency tasks: normative data in an elderly population of 70 years old and over from the PAQUID cohort]. Rev Neurol (Paris). 2010 Jun-Jul;166(6-7):594-605. doi: 10.1016/j.neurol.2010.01.012. Epub 2010 Mar 16. French. — View Citation
Roy, A., Fournet, N., Le Gall, D., Roulin, J. L. BRIEF. Inventaire d'évaluation comportementale des fonctions exécutive - Adaptation française. Hogrèfe France Editions (2014).
Tombaugh TN. Trail Making Test A and B: normative data stratified by age and education. Arch Clin Neuropsychol. 2004 Mar;19(2):203-14. doi: 10.1016/S0887-6177(03)00039-8. — View Citation
Vandenberghe M, Michiels J, Vanderaspoilden V, Claes T, Fery P. [Creation and normalisation of a verbal episodic memory task in elderly adults: "GERIA-12"]. Rev Neurol (Paris). 2015 Dec;171(12):853-65. doi: 10.1016/j.neurol.2015.08.001. Epub 2015 Nov 10. French. — View Citation
Vergauwe E, Ricker TJ, Langerock N, Cowan N. What do people typically do between list items? The nature of attention-based mnemonic activities depends on task context. J Exp Psychol Learn Mem Cogn. 2019 May;45(5):779-794. doi: 10.1037/xlm0000625. Epub 2018 Jul 19. — View Citation
Zheng C, Zhang RS, Wan T, Zhao JS. Topological Alterations of Working Memory Impairment in Aged Patients With Vascular Dementia. Front Aging Neurosci. 2021 Oct 4;13:741445. doi: 10.3389/fnagi.2021.741445. eCollection 2021. — View Citation
* Note: There are 27 references in all — Click here to view all references
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Memory performance in the Working memory task | Percentage of correct immediate recall, computed with strict serial recall criterion (item identity + correct position) and computed with item recall criterion (item identity only). | 15 minutes | |
Primary | Processing performance in the Working memory task | Percentage of correct response in the spatial part of working memory task | 15 minutes | |
Primary | Reaction time | Reaction time for each distractor (in ms) in the spatial part of working memory task | 30 minutes | |
Secondary | Mini-Mental State Examination (MMSE) | MMSE is a test evaluate global cognitive functioning Score from 0 to 30 A higher score mean a better cognitive efficiency | 15 minutes | |
Secondary | Digit span forward WAIS IV (digit number) | The participant's span is noted, corresponding to the longest number of sequential digits that can be repeated forward. | 5 minutes | |
Secondary | Digit span forward WAIS IV (standard note) | This scale permitted to obtain a standard note from 0 to 19 A higher score means a better performance | 5 minutes | |
Secondary | Digit span backward WAIS IV (digit number) | The participant's span is noted, corresponding to the longest number of sequential digits that can be repeated backward. | 5 minutes | |
Secondary | Digit span backward WAIS IV (standard note) | This scale permitted to obtain a standard note from 0 to 19 A higher score means a better performance | 5 minutes | |
Secondary | Stroop Test - denomination part | the denomination part of stroop test measures processing speed time is taken, in seconds | 30 secondes | |
Secondary | Stroop Test - minor interference part (Time) | this part of stroop test measures low inhibition process time is taken, in seconds | 30 secondes | |
Secondary | Stroop Test - minor interference part (errors) | this part of stroop test measures low inhibition process number of errors is noted, from 0 to 24 | 30 secondes | |
Secondary | Stroop Test - major interference part (time) | this part of stroop test measures strong inhibition process time is taken, in seconds | 90 secondes | |
Secondary | Stroop Test - major interference part (errors) | this part of stroop test measures strong inhibition process number of errors is noted, from 0 to 24 | 90 secondes | |
Secondary | Trail Making Test - Part A (time) | This test evaluate motor speed processing Time in seconds | 2 minutes | |
Secondary | Trail Making Test - Part A (errors) | This test evaluates motor speed processing Number of errors is noted | 2 minutes | |
Secondary | Trail Making Test - Part B (time) | This test evaluates mental flexibility Time in seconds | 5 minutes | |
Secondary | Trail Making Test - Part B (errors) | This test evaluates mental flexibility Number of errors is noted | 5 minutes | |
Secondary | Category fluences | Number of correct words is noted | 5 minutes | |
Secondary | Memory evaluation (16-item Free and Cued Recall, or GERIA-12) | These tests evaluate verbal episodic memory Scores are noted for each trail, from 0 to 16 (RL-RI/16) or 0 to 12 (Geria-12) A higher score means a better performance | 40 minutes | |
Secondary | Naming task | This test evaluate the capacity to correctly name a picture Score is noted, from 0 to 40 A higher score means a better performance | 40 minutes | |
Secondary | Behavior rating inventory of executive function | Questionnaire (french version) on patient's daily executive functioning, completed by a relative of the patient, if present Global score from 75 to 225, composing by several composite scores. A higher score means a more severe executive dysfonctionning in daily life | 10 minutes | |
Secondary | Instrumental Activities of Daily Living | Questionnaire completed by a professional (nurse or doctor) with the patient and an accompagniant if present Score from 0 to 8 A higher score mean a better autonomy in daily life | 5 minutes | |
Secondary | Activities of Daily Living | Questionnaire completed by a professional (nurse or doctor) with the patient and an accompagniant if present Score from 0 to 6 A higher score mean a better autonomy in daily life | 5 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04044495 -
Sleep, Rhythms and Risk of Alzheimer's Disease
|
N/A | |
Completed |
NCT04079803 -
PTI-125 for Mild-to-moderate Alzheimer's Disease Patients
|
Phase 2 | |
Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
Recruiting |
NCT04520698 -
Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease
|
N/A | |
Active, not recruiting |
NCT04606420 -
Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease
|
N/A | |
Recruiting |
NCT05820919 -
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
|
N/A | |
Terminated |
NCT03672474 -
REGEnLIFE RGn530 - Feasibility Pilot
|
N/A | |
Completed |
NCT03430648 -
Is Tau Protein Linked to Mobility Function?
|
||
Recruiting |
NCT04949750 -
Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease
|
N/A | |
Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
Recruiting |
NCT05557409 -
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation
|
Phase 3 | |
Recruiting |
NCT05288842 -
Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
|
||
Completed |
NCT06194552 -
A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07
|
Phase 1 | |
Completed |
NCT03239561 -
Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants
|
Early Phase 1 | |
Completed |
NCT03184467 -
Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients
|
Phase 2 | |
Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Terminated |
NCT03487380 -
Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease
|
N/A | |
Completed |
NCT05538455 -
Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases
|
N/A | |
Recruiting |
NCT05328115 -
A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease
|
Phase 1 | |
Completed |
NCT05562583 -
SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support
|
N/A |